 |
 |
|
|
|
|
Title: |
US5571698:
Directed evolution of novel binding proteins
[ Derwent Title ]

|
Country: |
US United States of America

|
| |
Inventor: |
Ladner, Robert C.; Ijamsville, MD
Guterman, Sonia K.; Belmont, MA
Roberts, Bruce L.; Milford, MA
Markland, William; Milford, MA
Ley, Arthur C.; Newton, MA
Kent, Rachel B.; Boxborough, MA

|
Assignee: |
Protein Engineering Corporation, Cambridge, MA
other patents from PROTEIN ENGINEERING CORPORATION (456956) (approx. 5)
News, Profiles, Stocks and More about this company

|
Published / Filed: |
1996-11-05
/ 1993-06-18

|
Application Number: |
US1993000057667

|
IPC Code: |
Advanced:
A61K 8/64;
A61Q 11/00;
C07K 1/04;
C07K 1/107;
C07K 14/435;
C07K 14/805;
C07K 14/81;
C12N 7/00;
C12N 15/10;
C40B 40/02;
A61K 38/00;
Core:
A61K 8/30;
C07K 1/00;
C07K 14/795;
more...
IPC-7:
C12N 25/62;

|
ECLA Code: |
C40B40/02; C07K1/04C; C07K1/107; C07K14/435A2B; C07K14/805; C07K14/81B1A; C07K14/81B1A1; C12N7/00; C12N15/10C1; K61K38/00; M07K207/00; M12N795/04A;

|
U.S. Class: |
Current:
435/069.7;
435/006;
435/069.1;
435/252.3;
435/320.1;
435/477;
Original:
435/069.7;
435/006;
435/064.1;
435/172.3;
435/252.3;
435/320.1;

|
Field of Search: |
435/006,64.1,64.7,172.3,252.3,320.1

|
Priority Number: |
| 1993-06-18 |
US1993000057667 |
| 1991-03-01 |
US1991000664989 |
| 1990-03-02 |
US1990000487063 |
| 1988-09-02 |
US1988000240160 |

|
Abstract: |
In order to obtain a novel binding protein against a chosen target, DNA molecules, each encoding a protein comprising one of a family of similar potential binding domains and a structural signal calling for the display of the protein on the outer surface of a chosen bacterial cell, bacterial spore or phage (genetic package) are introduced into a genetic package. The protein is expressed and the potential binding domain is displayed on the outer surface of the package. The cells or viruses bearing the binding domains which recognize the target molecule are isolated and amplified. The successful binding domains are then characterized. One or more of these successful binding domains is used as a model for the design of a new family of potential binding domains, and the process is repeated until a novel binding domain having a desired affinity for the target molecule is obtained. In one embodiment, the first family of potential binding domains is related to bovine pancreatic trypsin inhibitor, the genetic package is M13 phage, and the protein includes the outer surface transport signal of the M13 gene III protein.

|
Attorney, Agent or Firm: |
Cooper, Iver P. ;

|
Primary / Asst. Examiners: |
Ulm, John;

|
Maintenance Status: |
CC Certificate of Correction issued

|
INPADOC Legal Status: |
Show legal status actions
Family Legal Status Report

|
 |
 |
|
|
|
|
Parent Case: |
This is a continuation of application Ser. No. 07/664,989 filed Mar. 1, 1991, now U.S. Pat. No. 5,223,409, which is a continuation-in-part of application Ser. No. 07/487,063 filed Mar. 2, 1990, now abandoned, which is a continuation-in-part of application Ser. No. 07/240,160 filed Sep. 2, 1988, now abandoned, the contents of all of which are hereby incorporated by reference.

|
Designated Country: |
BB BG BR CS HU KP KR LK MG MN MW OA PL RO SD SU BE CH DK FR GB GR IT LI LU MC NL SE FI NO

|
Family: |
Show 115 known family members

|
First Claim:
Show all 83 claims |
We claim:
1. A method of obtaining a nucleic acid encoding a binding protein having a proteinaceous binding domain that binds a predetermined target material comprising:
- a) preparing a variegated population of amplifiable genetic packages, said genetic packages being selected from the group consisting of cells, spores and viruses, each said genetic package being genetically alterable and having an outer surface including a genetically determined outer surface protein, each package including a first nucleic acid construct coding for a chimeric potential binding protein, each said chimeric protein comprising and each said construct comprising nucleic acid encoding (i) a potential binding domain which is a mutant of a predetermined domain of a predetermined parental protein other than a single chain antibody, and (ii) an outer surface transport signal for obtaining the display of the potential binding domain on the outer surface of the genetic package, the expression of which construct results in the display of said chimeric potential binding protein and its potential binding domain on the outer surface of said genetic package; and wherein said variegated population of genetic packages collectively display a plurality of different potential binding domains, the differentiation among said plurality of different potential binding domains occurring through the at least partially random variation of one or more predetermined amino acid positions of said parental binding domain to randomly obtain at each said position an amino acid belonging to a predetermined set of two or more amino acids; the amino acids of said set occurring at said position in statistically predetermined expected proportions, said genetic packages being amplifiable in cell culture and separable on the basis of the potential binding domain displayed thereon,
- b) causing the expression of said chimeric potential binding proteins and the display of said potential binding domains on the outer surface of said packages;
- c) contacting said packages with the predetermined target material such that said potential binding domains and the target material may interact;
- d) separating packages displaying a potential binding domain that binds the target material from packages that do not so bind, and
- e) recovering at least one package displaying on its outer surface a chimeric binding protein comprising a successful binding domain (SBD) which bound said target, said package comprising nucleic acid encoding said successful binding domain, and amplifying said SBD-encoding nucleic acid in vivo or in vitro,
- with the proviso that when the target is an antibody, the predetermined parental protein is not an antigen specifically bound by that antibody.

|
Background / Summary: |
Show background / summary

|
Drawing Descriptions: |
Show drawing descriptions

|
Description: |
Show description

|
Forward References: |
Show 148 U.S. patent(s) that reference this one

|
 |
 |
|
|
|
|
Foreign References: |

|
Other Abstract Info: |
CHEMABS 113(13)110488Z
CHEMABS 117(04)033461P
CHEMABS 118(17)161067X
CHEMABS 119(23)242941A
CHEMABS 127(18)244812Y
DERABS C1990-115996
DERABS C1992-150877
DERABS C1992-331666
DERABS C1992-331723
DERABS C1992-331725

|
Other References: |
Immumogenicity and Epitope Mapping of Foreign Sequences via Genetically Engineered Filamentous Phage; Vidal F. de la Cruz, Altaf A. Lal and Thomas F. McCutchan; The Journal of Biological Chemistry vol. 263, No. 9, Issue of Mar. 25, pp. 431804322. 1988.
In Vitro Genertic Constructions Devised to Express Given Antigenic Determinants at the Surface of Gram-negative Bacteria, Bernadette Bouges-Bocquet, Jean-Luc Guesdon, Christian Marchal and Maurice Hofnung:Unite de Programmation Moleculaire et Toxicologie Genetique CNRSLA 271, INSERM U.163, Instit Pasteur, 75015 Paris, France.
Probing the topology of a bacterial membrane protein by genetic insertion of a foreign epitope: expression at the cell surface, The EMBO Journal.
Alain Charbit, Jean Claude Boulain, Antoinette Ryter and Maurice Hofnung The EMBO Journal vol. 5, No. 11, pp. 3029-3037, 1986.
Presentation of Two Epitopes of the preS2 Region of Hepatitis B Virus on Live Recombinant Bacteria: Alain Charbit, Eliane Sobczak, Marie-Louise.
Michel, Annie Molla, Pierre Tiollais and Maurice Hofnung; J. Immunology, vo. 139, 1658-1664, No. 5 Sep. 1, 1987.
Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion Surface: Science 228 ('85) 1315017 PEC0406.
Ilichov et al., (1989), Dolle Ahad Nauk SSSR 307: 481-483.
Smith et al., (1986), J. Mol. Biol. 189:227-238.
(12 pages)
Cited by 4 patents
Subcellular localization of a PhoE-LacZ fusion protein in E. coli by protease accessibility experiments reveals an inner-membrane-spanning form of the ptotein; Jan Tommassen and Toon de Kroon;FEB 05071, vol. 221 No. 2, 226-230, Sep. 1987.
Uses of lac Fusions for the Study of Biological Problems; Thomas J. Silhavy and Jonathan R. Beckwith: Microbiological Reviews, Dec. 1985, pp. 398-418, vol. 49, No. 4--American Society for Microbiology.
(21 pages)
Cited by 17 patents
Sequence Information within the lamB Gene is Required for Proper Routing of the Bacteriophage γ Receptor Protein go the Outer Membrane of Eschichia coli K-12; Michael N. hall, Maxime Schwartz and Thomas J. Silhavy; J. Med. Biol (1982) 156, 93-112.
(20 pages)
Cited by 7 patents
Selection for Mutants Altered in the Expression or Export of Outer Membrane Porin OmpF; Erica J. Sodergren, Jane Davidson, Ronald K. Taylor and Thomas J. Silhavy; J. of Bacteriology, Jun. 1985, pp. 1047-1053.
(7 pages)
Cited by 7 patents
Biologe Moleculaire-Une methode genetique pour exposer un epitope chois a la surface de la bacterie Escherichia colo. Perspectives Note of Alain Charbit, Jean-Claude Boulain et Maurice Hofnung; C. R. Acad Sc. Paris, t.302, Serie III, No. 17, 1986.
Affinity-Chromatographic Studies Based on the Binding-Specificity of the Lambda Receptor of Escherichia col I. T. Ferenci; Ann Microbiol. (Inst. Pasteur) 1982, 133 A, 167-169.
(3 pages)
Cited by 5 patents
Directed Evolution of the Lambda Receptor of Escherichia coli through Affinity Chromatographic Selection: Thomas Ferenci and Kin-Sang Lee J. Bol. Biol. (1982) 160, 431-444.
(14 pages)
Cited by 7 patents
Isolation by Affinity Chromatography, of Mutant Escherichia coli Cells with Novel Regulation of lamB Expression; Thomas Ferenci and Kin-Sang Lee J. of Bacteriology, May 1983, pp. 984-987, vol. 154, No. 2.
Affinity Engineering of Maltoporin; Variats with Enhanced Affinity for Particular Ligands; Ann clune, Kin-Sang Lee and Thomas Ferenci Biochemical and Biophysical Research Communications, vol. 121, No. 1, 1984 pp. 34-40.
(7 pages)
Cited by 9 patents
Sequence determinants in the labB gene of Escherichia coli influencing the binding and pore selectivity of maltoporin; Hans-Georg Heine, Joanna Kyngdon and Thomas Ferenci; Gene, 53 (1987)287-292.
(6 pages)
Cited by 6 patents
Commentaries; Protein Engineering, vol. 1, No. 1, pp. 3-6, 1986.
Cloning of random-sequence oligodeoxynucleotides; Arnold R. Oliphant, Alexander L. Nussbaum and Kevin Struhl; Gene, 44 (1986) 177-183.
(7 pages)
Cited by 248 patents
The Use of Random-Sequence Oligonuceotides for Determining Consensus Sequences; Arnold R. Oliphant and Kevin Struhl; Methods in Enzymology, vol. 155, pp. 568-582 (1987).
(14 pages)
Cited by 163 patents
Combinatorial Cassette Mutagenesis as a Probe of the Informational Content of Protein Sequences: John F. Reidhaar-Olson and Robert T. Sauer; Research Articles, Science, vol. 241, 1 Jul. 1988, pp. 53-57.
(5 pages)
Cited by 89 patents
Mutagenesis of the Arc Repressor Using Synthetic Primers with Random Nucleotide Substitutions; Andrew K. Vershon, Karen Blackmer and Robert T. Sauer; Protein Engineering, Applications in Science, Medicine and Industry; 1986, pp. 243-257.
Isolation and Analysis of Arc Repressor Mutants: Evidence for an Unusual Mechanism of DNA Binding; Andrew K. Vershon, James U. Bowie, Theresa M. Karplus and Robert T. Sauer; Proteins: Structure, Function, and Genetics 1:302-311 (1986).
Bacteriophage .lambda. cro mutations: Effects on activity and intracellular degradation: Andrew A. Pakula, Vincent B. Young and Robert T. Sauer; Proc. Natl. Acad. Sci, USA, vol. 83, pp. 8829-8833, Dec. 1986.
(5 pages)
Cited by 9 patents
Phage Lambda Repressor Revertants--Amino Acid Substitutions that Restore Activity to Mutant Proteins; Michael H. Hecht and Robert T. Sauer; J. Med. Biol. (1985) 186, 53-63.
(11 pages)
Cited by 9 patents
Lambda Repressor Mutations That Increase the Affinity and Specificity of Operator Binding: Hillary C. M. Nelson and Robert T. Sauer; Cell, vol. 42, 549-558, Sep. 1985.
(10 pages)
Cited by 9 patents
Intersaction of Mutant .lambda. Repressors with Operator and Non-Operator DNA; Hillary C. M. Nelson and Robert T. Sauer; J. Med. Biol. (1986) 192, 27-38.
(12 pages)
Cited by 7 patents
Amino Acid Replacements that Compensate for a Large Polypeptide Deletion in an Enzyme; Carvin Ho, Maria Jasin and Paul Schimmel; Science, vol. 229, pp. 389-393; 26 Jul. 1985.
(5 pages)
Cited by 7 patents
Mutagenesis by random linker insertion into the lamB gene of Escherichia coli K12; Jean Claude Boulain, Alina Charbit and Maurice Hofnung; Med. Gen. Genes (1986) 205: 339-348.
(10 pages)
Cited by 13 patents
Recruitment of substrate-specificity properties from one enzyme into a related one by protein engineering; James A. Wells, Brian C. Cunningham.
Thomas P. Graycar, and David A. Estell; Proc. Natl. Acad. Sci. USA, vol. 84, pp. 5167-5171, Aug. 1987.
(5 pages)
Cited by 45 patents
Mutants of Bovine Pancreatic Trypsin Inhibitor Lacking Cysteines 14 and 38 Can Fold Properly; Cara Berman Marks, Hossein Naderi, Phyllis Anne Kosen, Irwin D. Kuntz and Stephen Anderson; Science vol. 235, pp. 1370-1375, Mar. 1987.
(4 pages)
Cited by 14 patents
Synthesis and Characterization of a Pancreatic Trypsin Inhibitor Homologue and a Model Inhibitor; Nget Hong Tan and E. T. Kaiser; Biochemistry, vol. 16, No. 8, pp. 1531-1541, Apr. 19, 1977.
(11 pages)
Cited by 13 patents
Transition-state stabilization in the medhanism of tyrosyl-tRNA synthetase revealed by protein engineering; Robin J. Leatherbarrow, Alan R. Fersht and Greg Winter; Proc. Natl. Acad. Sci. USA, Fol 82, pp. 7840-7844, Dec. 1985.
(5 pages)
Cited by 7 patents
The cloning and expression of an anti-peptide antibody: a system for rapid analysis of the binding properties of engineered antibodies; S. Roberts and A. R. Rees; Protein Engineering, vol. 1, No. 1, pp. 59-65, 1986.
(7 pages)
Cited by 9 patents
Production in Escherichia coli and one-step purification of bifunctional hybrid proteins which bind maltose: hugues Redouelle and Pascale Duplay; Bur. J. Biochem. 171, 541-549 (1988).
(9 pages)
Cited by 14 patents
Expression, exportation et purification en une etape de proteines par fusion a la proteine MalE d'E. coli; Hughes Bedouelle, Pascale Duplay and Maruice Hofnung; C. R. Acad. Sci. Paris, t. 305, Serie III, pp. 623-626, 1987.
(4 pages)
Cited by 4 patents
Linker Mutagenesis in the Gene of an Outer Membrane Protein of Escherichia coli, LamB; B. Bouges-Bocquet, H. Villarroya and M. Hofnung J. Cellular Biochemistry 24: 217-228 (1984).
(12 pages)
Cited by 7 patents
An Epitope Library; Jamie K. Scott and George P. Smith, Science (Preprint).
Antibody-Selectable Filamentous fd Phage Vectors; Affinity Purification of Target Genes Parmley and Smith; Gene, 73:305-18 (1988).
Valenzuela, Pablo et al, "Antigen Engineering in Yeast: Synthesis and Assembly of Hybrid Hepatitis B Surface Antigen-Herpes Simplex 1 gD Particles," Bio/Technology, vol. 3, pp. 323-326, Apr. 1985.
(4 pages)
Cited by 38 patents
Charbit, et al.; Versatility of a vector for expressing foreign polypeptides at the surface of gram-negative bacteria; Gene (1988); 70(1):181-9.
(9 pages)
Cited by 26 patents
von Heijne, et al.; Membrane proteins: from sequence to structure; Protein Engineering; (1990) 4(2):109-112.
(4 pages)
Cited by 7 patents
Fijima et al. 1986 (Mar.) Agric. Biol. Chem 50(3) 589-592.
Fadenci T. 1984 Trends in Biol. Sci. 9: 44-48.

|


|
Nominate this for the Gallery...

|
|